namzarichcp.com
NAMZARIC - Important Safety Information
http://www.namzarichcp.com/important-safety-information
NAMZARIC is contraindicated in patients with known hypersensitivity to memantine hydrochloride, donepezil hydrochloride, piperidine derivatives, or to any excipients used in the formulation. NAMZARIC is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia. Peptic Ulcer Disease and Gastrointestinal Bleeding. NAMZARIC can cause diarrhea, nausea, and vomiting. Although in most cases these effects have been mild and transient, sometimes lasting one to three weeks, and have resolv...
allergan.com
Specialty Brand Pharmaceutical Products - Allergan - Allergan
http://www.allergan.com/products/key-products/specialty-products
Stock Chart and Quote. Stock Chart and Quote. Executive Officers and Directors. Executive Officers and Directors. Audit and Compliance Committee. Nominating and Corporate Governance Committee. Quality and Innovation Committee. We Live Open Science. We Live Open Science. R&D Areas of Focus. R&D Areas of Focus. Participating in an Allergan Clinical Trial. Participating in an Allergan Clinical Trial. Clinical Trial results sharing. Clinical Trial results sharing. Patient Safety and Product Quality. T he All...
namzarichcp.com
Resources | NAMZARIC® (memantine HCl extended release and donepezil HCl) capsules | For Healthcare Professionals Only
http://www.namzarichcp.com/resources
Support for your patients and. Help your patients receive a 30-day trial supply. Of NAMZARIC at $0 out-of-pocket cost. Have your patients visit NAMZARIC.com/Trial-Offer. Have your patients visit NAMZARIC.com/Trial-Offer. An online resource filled with personal stories, caregiver videos, related links, and other tools that can help caregivers provide the best support for their loved ones. NAMZARIC is likely to exaggerate succinylcholine-type muscle relaxation during anesthesia. NAMZARIC may have vagotonic...
namzarichcp.com
Efficacy | NAMZARIC® (memantine HCl extended release and donepezil HCl) capsules | For Healthcare Professionals Only
http://www.namzarichcp.com/efficacy
Combination therapy demonstrated improvement. In cognition and global function. In the overall study population. Memantine HCl) 28 mg. AChEI demonstrated statistically significantly superior improvement in cognition vs placebo AChEI treatment at 24 weeks, using an LOCF* analysis (. At 24 weeks, there was a 2.6 unit mean difference between treatment groups on the SIB. LOCF=last observation carried forward. SEM=Standard Error of the Mean. In a subset of the overall study population. Memantine HCl) 28 mg.
allergan.com
Specialty Brand Pharmaceutical Products - Allergan - Allergan
http://www.allergan.com/products/medical_aesthetics/natrelle_collection.htm
Stock Chart and Quote. Stock Chart and Quote. Executive Officers and Directors. Executive Officers and Directors. Audit and Compliance Committee. Nominating and Corporate Governance Committee. Quality and Innovation Committee. We Live Open Science. We Live Open Science. R&D Areas of Focus. R&D Areas of Focus. Participating in an Allergan Clinical Trial. Participating in an Allergan Clinical Trial. Clinical Trial results sharing. Clinical Trial results sharing. Patient Safety and Product Quality. T he All...
alzdiscovery.com
Alzheimer's Diagnosis + Treatments | Alzheimer's Drug Discovery Foundation
http://www.alzdiscovery.com/alzheimers-disease/diagnosis-treatment
Annual Reports and Financials. Signs + Symptoms. Diagnosis + Treatments. ADDF in the Media. Alzheimer’s Diagnosis Treatments. Scientists have made great strides in accurately diagnosing Alzheimers disease. Though current drugs only treat the symptoms of the disease, several potential drugs in late-stage clinical trials offer hope for slowing the progress of Alzheimers. Questions about the patients health, past medical problems and ability to carry out daily tasks. Medical tests such as brain scans. For m...
alzdiscovery.org
Alzheimer's Diagnosis + Treatments | Alzheimer's Drug Discovery Foundation
http://www.alzdiscovery.org/alzheimers-disease/diagnosis-treatment
Annual Reports and Financials. Signs + Symptoms. Diagnosis + Treatments. ADDF in the Media. Alzheimer’s Diagnosis Treatments. Scientists have made great strides in accurately diagnosing Alzheimers disease. Though current drugs only treat the symptoms of the disease, several potential drugs in late-stage clinical trials offer hope for slowing the progress of Alzheimers. Questions about the patients health, past medical problems and ability to carry out daily tasks. Medical tests such as brain scans. For m...
alzdiscovery.net
Alzheimer's Diagnosis + Treatments | Alzheimer's Drug Discovery Foundation
http://www.alzdiscovery.net/alzheimers-disease/diagnosis-treatment
Annual Reports and Financials. Signs + Symptoms. Diagnosis + Treatments. ADDF in the Media. Alzheimer’s Diagnosis Treatments. Scientists have made great strides in accurately diagnosing Alzheimers disease. Though current drugs only treat the symptoms of the disease, several potential drugs in late-stage clinical trials offer hope for slowing the progress of Alzheimers. Questions about the patients health, past medical problems and ability to carry out daily tasks. Medical tests such as brain scans. For m...
namzarichcp.com
Dosing | NAMZARIC® (memantine HCl extended release and donepezil HCl) capsules | For Healthcare Professionals Only
http://www.namzarichcp.com/dosing
FOR PATIENTS WITH MODERATE TO SEVERE AD. Patients stabilized on memantine HCI and donepezil HCI 10 mg can transition to NAMZARIC the very next day. Patients who are on a stable regimen of NAMENDA 10 mg twice daily and donepezil HCl 10 mg can transition directly to NAMZARIC 28 mg/10 mg once-daily capsules the evening following the last dose of NAMENDA and donepezil HCl. Patients should take NAMZARIC in the evening, just before bedtime. Patients should take NAMZARIC in the evening, just before bedtime.